GlassScriptPhysician profile
Nikhil C Patel
NPI 1053345926
$113,409.40
in general payments reported to CMS, 2019-2025
23 companies · $36K in 2025
The $36K reported for 2025 was more than what 96% of Vascular & Interventional Radiology providers received nationally (typical 2025 total: $537).
See the full distribution for Vascular & Interventional Radiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $314 · 2020: $834 · 2021: $2,714 · 2022: $11K · 2023: $29K · 2024: $34K · 2025: $36K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $95K · Food and Beverage: $3,328.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $95,083.34 |
| Food and Beverage | $3,327.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $106,969.78 | 2021-2025 | Auryon Laser System 100-120 Vac, Venacure 1470 Pro, Auryon Laser System 100-120 Vac |
| Boston Scientific Corporation | $2,570.65 | 2019-2025 | General - Balloons, Peripheral Rotalink Plus, General - Vascular Intervention |
| Avinger INC. | $529.03 | 2020-2023 | Pantheris |
| Cardiovascular Systems INC. | $507.79 | 2021-2023 | Diamondback Peripheral |
| Veryan Medical Incorporated | $430.54 | 2020-2023 | Biomimics 3d Vascular Stent System |
| Abbott Laboratories | $346.93 | 2021-2023 | Diamondback Peripheral, Ionicrf |
| Janssen Pharmaceuticals, INC | $297.13 | 2020-2021 | |
| Endologix LLC | $264.67 | 2025 | Torus Stent Graft System, Endocross Device |
| Philips North America LLC | $255.62 | 2022-2025 | (Dd1) Duo Hybrid, Turbo Elite, (Az7) Lasers |
| Reflow Medical INC | $181.29 | 2024-2025 | |
| Biotronik INC. | $152.46 | 2019-2023 | Oscar |
| Balt USA, LLC | $147.86 | 2022 | |
| Medtronic, INC. | $120.09 | 2023 | Hawkone |
| Walk Vascular, LLC | $116.25 | 2020 | |
| Novo Nordisk INC | $115.32 | 2022 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardinal Health 200 LLC | $101.01 | 2020 | |
| Cordis US Corp. | $93.87 | 2023 | Saber, S.M.A.R.T. Control |
| Vasorum USA INC. | $82.14 | 2023 | Celt Acd |
| Sirtex Medical INC | $37.60 | 2019 | |
| Bard Peripheral Vascular, INC. | $28.87 | 2025 | Venovo |
| Becton, Dickinson and Company | $24.29 | 2025 | Rotarexs 6 F X 135 Cm |
| Nevro Corp. | $19.23 | 2023 | Senza |
| Merck Sharp & Dohme LLC | $16.98 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nikhil Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.